ClearPoint Neuro (CLPT) Raw Materials (2024 - 2026)

ClearPoint Neuro (CLPT) reported Raw Materials of $6.7 million for Q1 2026, down 4.68% sequentially from $7.1 million in Q4 2025.

ClearPoint Neuro (CLPT) Raw Materials (2024 - 2026) Analysis & Trends

ClearPoint Neuro (CLPT) has 3 years of Raw Materials data on file, last reported at $6.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Raw Materials changed N/A year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (changed N/A YoY), and the FY2025 full-year result was $7.1 million, up 28.15% from the prior year.
  • Raw Materials fell to $6.7 million in Q1 2026, from $7.1 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $7.1 million in Q4 2025 to a low of $5.5 million in Q4 2024.
  • A 3-year average of $6.2 million and a median of $6.1 million in 2025 frame the typical range for Raw Materials.
  • Peak annual rise in Raw Materials reached 28.15% in 2025, while the deepest fall reached 28.15% in 2025.
  • Tracing CLPT's Raw Materials over 3 years: stood at $5.5 million in 2024, then increased by 28.15% to $7.1 million in 2025, then fell by 4.68% to $6.7 million in 2026.
  • Business Quant data shows CLPT's Raw Materials at $6.7 million in Q1 2026, $7.1 million in Q4 2025, and $6.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 ClearPoint Neuro 434.51 Mn 398.91 Mn 7.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.72 Mn
Dec 31, 2025 7.05 Mn
Sep 30, 2025 6.12 Mn
Jun 30, 2025 5.68 Mn
Dec 31, 2024 5.50 Mn